These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31299951)

  • 1. Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort.
    Organ LA; Duggan AR; Oballa E; Taggart SC; Simpson JK; Kang'ombe AR; Braybrooke R; Molyneaux PL; North B; Karkera Y; Leeming DJ; Karsdal MA; Nanthakumar CB; Fahy WA; Marshall RP; Jenkins RG; Maher TM
    Respir Res; 2019 Jul; 20(1):148. PubMed ID: 31299951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study.
    Jenkins RG; Simpson JK; Saini G; Bentley JH; Russell AM; Braybrooke R; Molyneaux PL; McKeever TM; Wells AU; Flynn A; Hubbard RB; Leeming DJ; Marshall RP; Karsdal MA; Lukey PT; Maher TM
    Lancet Respir Med; 2015 Jun; 3(6):462-72. PubMed ID: 25770676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Turnover of type I and III collagen predicts progression of idiopathic pulmonary fibrosis.
    Jessen H; Hoyer N; Prior TS; Frederiksen P; Karsdal MA; Leeming DJ; Bendstrup E; Sand JMB; Shaker SB
    Respir Res; 2021 Jul; 22(1):205. PubMed ID: 34261485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal serological assessment of type VI collagen turnover is related to progression in a real-world cohort of idiopathic pulmonary fibrosis.
    Jessen H; Hoyer N; Prior TS; Frederiksen P; Rønnow SR; Karsdal MA; Leeming DJ; Bendstrup E; Sand JMB; Shaker SB
    BMC Pulm Med; 2021 Nov; 21(1):382. PubMed ID: 34814865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High turnover of types III and VI collagen in progressive idiopathic pulmonary fibrosis.
    Hoyer N; Jessen H; Prior TS; Sand JMB; Leeming DJ; Karsdal MA; Åttingsberg EKA; Vangsgaard GKM; Bendstrup E; Shaker SB
    Respirology; 2021 Jun; 26(6):582-589. PubMed ID: 33834579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study.
    Maher TM; Oballa E; Simpson JK; Porte J; Habgood A; Fahy WA; Flynn A; Molyneaux PL; Braybrooke R; Divyateja H; Parfrey H; Rassl D; Russell AM; Saini G; Renzoni EA; Duggan AM; Hubbard R; Wells AU; Lukey PT; Marshall RP; Jenkins RG
    Lancet Respir Med; 2017 Dec; 5(12):946-955. PubMed ID: 29150411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic Biomarkers of Collagen and Elastin Turnover Are Associated With Clinically Relevant Outcomes in COPD.
    Stolz D; Leeming DJ; Kristensen JHE; Karsdal MA; Boersma W; Louis R; Milenkovic B; Kostikas K; Blasi F; Aerts J; Sand JMB; Wouters EFM; Rohde G; Prat C; Torres A; Welte T; Roth M; Papakonstantinou E; Tamm M
    Chest; 2017 Jan; 151(1):47-59. PubMed ID: 27575358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cluster analysis of blood biomarkers to identify molecular patterns in pulmonary fibrosis: assessment of a multicentre, prospective, observational cohort with independent validation.
    Fainberg HP; Moodley Y; Triguero I; Corte TJ; Sand JMB; Leeming DJ; Karsdal MA; Wells AU; Renzoni E; Mackintosh J; Tan DBA; Li R; Porte J; Braybrooke R; Saini G; Johnson SR; Wain LV; Molyneaux PL; Maher TM; Stewart ID; Jenkins RG
    Lancet Respir Med; 2024 Sep; 12(9):681-692. PubMed ID: 39025091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated plasma proteomics and lung transcriptomics reveal novel biomarkers in idiopathic pulmonary fibrosis.
    Sivakumar P; Ammar R; Thompson JR; Luo Y; Streltsov D; Porteous M; McCoubrey C; Cantu E; Beers MF; Jarai G; Christie JD
    Respir Res; 2021 Oct; 22(1):273. PubMed ID: 34689792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nintedanib modulates type III collagen turnover in viable precision-cut lung slices from bleomycin-treated rats and patients with pulmonary fibrosis.
    Hesse C; Beneke V; Konzok S; Diefenbach C; Bülow Sand JM; Rønnow SR; Karsdal MA; Jonigk D; Sewald K; Braun A; Leeming DJ; Wollin L
    Respir Res; 2022 Aug; 23(1):201. PubMed ID: 35927669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated collagen turnover in women with angina pectoris without obstructive coronary artery disease: An iPOWER substudy.
    Nielsen SH; Mygind ND; Michelsen MM; Bechsgaard DF; Suhrs HE; Genovese F; Nielsen HB; Brix S; Karsdal M; Prescott E; Kastrup J
    Eur J Prev Cardiol; 2018 May; 25(7):719-727. PubMed ID: 29436257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LPA
    Decato BE; Leeming DJ; Sand JMB; Fischer A; Du S; Palmer SM; Karsdal M; Luo Y; Minnich A
    Respir Res; 2022 Mar; 23(1):61. PubMed ID: 35303880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2).
    Schett G; Loza MJ; Palanichamy A; FitzGerald O; Ritchlin C; Bay-Jensen AC; Nielsen SH; Gao S; Hsia EC; Kollmeier AP; Xu XL; Baribaud F; Sweet K
    Rheumatol Ther; 2022 Aug; 9(4):1017-1030. PubMed ID: 35352313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological investigation of the collagen degradation profile of patients with chronic obstructive pulmonary disease or idiopathic pulmonary fibrosis.
    Leeming DJ; Sand JM; Nielsen MJ; Genovese F; Martinez FJ; Hogaboam CM; Han MK; Klickstein LB; Karsdal MA
    Biomark Insights; 2012; 7():119-26. PubMed ID: 23012495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure.
    Kerbert AJC; Gupta S; Alabsawy E; Dobler I; Lønsmann I; Hall A; Nielsen SH; Nielsen MJ; Gronbaek H; Amoros À; Yeung D; Macnaughtan J; Mookerjee RP; Macdonald S; Andreola F; Moreau R; Arroyo V; Angeli P; Leeming DJ; Treem W; Karsdal MA; Jalan R
    JHEP Rep; 2021 Dec; 3(6):100355. PubMed ID: 34805815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous T-cell-attracting chemokine as a novel biomarker for predicting prognosis of idiopathic pulmonary fibrosis: a prospective observational study.
    Niwamoto T; Handa T; Murase Y; Nakatsuka Y; Tanizawa K; Taguchi Y; Tomioka H; Tomii K; Kita H; Uyama M; Tsuchiya M; Emura M; Kawamura T; Arai N; Arita M; Uno K; Yoshizawa A; Uozumi R; Yamaguchi I; Matsuda F; Chin K; Hirai T
    Respir Res; 2021 Jun; 22(1):181. PubMed ID: 34158044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misbalance in type III collagen formation/degradation as a novel serological biomarker for penetrating (Montreal B3) Crohn's disease.
    van Haaften WT; Mortensen JH; Karsdal MA; Bay-Jensen AC; Dijkstra G; Olinga P
    Aliment Pharmacol Ther; 2017 Jul; 46(1):26-39. PubMed ID: 28481042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between serological biomarkers of extracellular matrix turnover and lung fibrosis and pulmonary artery hypertension in patients with systemic sclerosis.
    Kubo S; Siebuhr AS; Bay-Jensen AC; Juhl P; Karsdal MA; Satoh Y; Todoroki Y; Nakano K; Nakayamada S; Tanaka Y
    Int J Rheum Dis; 2020 Apr; 23(4):532-539. PubMed ID: 32022479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum biomarkers of collagen turnover as potential diagnostic tools in diffuse systemic sclerosis: A cross-sectional study.
    Juhl P; Bay-Jensen AC; Karsdal M; Siebuhr AS; Franchimont N; Chavez J
    PLoS One; 2018; 13(12):e0207324. PubMed ID: 30507931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic Pulmonary Fibrosis: Prospective, Case-Controlled Study of Natural History and Circulating Biomarkers.
    Raghu G; Richeldi L; Jagerschmidt A; Martin V; Subramaniam A; Ozoux ML; Esperet CA; Soubrane C
    Chest; 2018 Dec; 154(6):1359-1370. PubMed ID: 30526970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.